
Elevix Pharmaceutical Private Limited
About Elevix Pharmaceutical Private Limited
Data last updated:
Elevix Pharmaceutical Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC315301. Its GSTIN is 27AAFCE2006E1Z7 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sharad Baburao Sherkar and Rani Sharad Sherkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 6 Plot No. 10 N – 4 Cidco, Aurangabad, Maharashtra, India – 431001.
As per the financials filed for FY 2024, the company reported a revenue of ₹20.46 Lakh, a decline of 13% compared to the previous year. For the same year it recorded a net loss of ₹3.35 Lakh (net margin -16.4%) and EBITDA of -₹2.97 Lakh (EBITDA margin -14.5%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No. 6 Plot No. 10 N – 4 Cidco, Aurangabad, Maharashtra, India – 431001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Elevix Pharmaceutical Private Limited
The main business activity of Elevix Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Elevix Pharmaceutical Private Limited FY 2025 filings available
Elevix Pharmaceutical Private Limited reported revenue of ₹20.46 Lakh (down 13% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Elevix Pharmaceutical Private Limited
Revenue fell 13% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA fell 85% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Elevix Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹2.97 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.35 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Elevix Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -14.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -16.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Elevix Pharmaceutical are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Elevix Pharmaceutical Private Limited
Elevix Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Xlinar Pharmaceuticals Private Limited | ₹22.18 Lakh (FY 2025) | •••• | •••• | •••• | Murshidabad, West Bengal, India | |
| Mysa Life Science Private Limited | ₹21.87 Lakh (FY 2025) | •••• | •••• | 650.0% | •••• | Premnagar, Uttar Pradesh, India |
| Zeokind India Private Limited | ₹21.54 Lakh (FY 2024) | •••• | •••• | •••• | Faridabad, Haryana, India | |
| Fealty Lifesciences Private Limited | ₹21.29 Lakh (FY 2025) | •••• | •••• | -12.0% | •••• | Aurangabad, Maharashtra, India |
| Medicament Formulation Private Limited | ₹20.86 Lakh (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Elevix Pharmaceutical Private Limited this company | ₹20.46 Lakh (FY 2024) | •••• | •••• | -13.0% | •••• | Aurangabad, Maharashtra, India |
| Maashree Ayurved Private Limited | ₹20.33 Lakh (FY 2024) | •••• | •••• | •••• | Thanesar, Haryana, India | |
| Ayush Herbal & Healthcare Private Limited | ₹19.83 Lakh (FY 2025) | •••• | •••• | 116.0% | •••• | Nahan, Himachal Pradesh, India |
| Point Bio Healthcare Private Limited | ₹19.82 Lakh (FY 2024) | •••• | •••• | -49.0% | •••• | Bhopal, Madhya Pradesh, India |
| Joyglad Healthcare Private Limited | ₹19.67 Lakh (FY 2025) | •••• | •••• | •••• | Bishrakh, Uttar Pradesh, India | |
| Himar Specialty Chemicals Private Limited | ₹19.41 Lakh (FY 2025) | •••• | •••• | 18381.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Elevix Pharmaceutical by revenue in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Elevix Pharmaceutical Private Limited
Elevix Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sharad Baburao Sherkar | Director | 04 Oct 2018 | 8 Years 0 Months | Current |
| Rani Sharad Sherkar | Director | 04 Oct 2018 | 8 Years 0 Months | Current |
Ownership and Shareholding of Elevix Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Elevix Pharmaceutical Private Limited
Elevix Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Elevix Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Elevix Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Elevix Pharmaceutical Private Limited
Elevix Pharmaceutical Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Rani Sharad Sherkar was appointed as Director on 04 Oct 2018.
Credit Ratings, Litigation & Regulatory Alerts for Elevix Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Elevix Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Elevix Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Elevix Pharmaceutical Private Limited
Elevix Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCE2006E1Z7 | Maharashtra | Active | 01 Jun 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Elevix Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elevix Pharmaceutical Private Limited
Elevix Pharmaceutical is an active private limited company based in Aurangabad, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 October 2018 (8+ years old) and is registered under CIN U74999MH2018PTC315301.
Elevix Pharmaceutical reported revenue of ₹20.46 Lakh for FY 2024 (down 13% YoY).
Elevix Pharmaceutical has 2 current directors:
- Sharad Baburao Sherkar - Director
- Rani Sharad Sherkar - Director
Elevix Pharmaceutical reported a net loss of ₹3.35 Lakh (net margin -16.4%) and EBITDA of -₹2.97 Lakh (EBITDA margin -14.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Elevix Pharmaceutical is 9% over three years. In the latest year (FY 2024) revenue fell 13%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Elevix Pharmaceutical is 27AAFCE2006E1Z7, registered in Maharashtra.
The CIN (Corporate Identification Number) of Elevix Pharmaceutical is U74999MH2018PTC315301. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elevix Pharmaceutical was incorporated on 04 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Elevix Pharmaceutical by revenue are Xlinar Pharmaceuticals Private Limited, Mysa Life Science Private Limited, Zeokind India Private Limited, Fealty Lifesciences Private Limited, Medicament Formulation Private Limited and 5 more, all in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations).
Rani Sharad Sherkar was appointed as Director on 04 Oct 2018. Sharad Baburao Sherkar was appointed as Director on 04 Oct 2018.
The registered office of Elevix Pharmaceutical is at Shop No. 6 Plot No. 10 N – 4 Cidco, Aurangabad, Maharashtra, India – 431001.